Diurnal Variation of Serum Iron, Iron-Binding Capacity, Transferrin Saturation, and Ferritin Levels
|
|
- Isabella McCoy
- 5 years ago
- Views:
Transcription
1 Clinical Chemistry / DIURNAL VARIATION OF SERUM IRON LEVELS Diurnal Variation of Serum Iron, Iron-Binding Capacity, Transferrin Saturation, and Ferritin Levels Jane C. Dale, MD, 1 Mary F. Burritt, PhD, 1 and Alan R. Zinsmeister, PhD 2 Key Words: Anemia, iron deficiency; Biological markers; Chemistry, clinical; Ferritin; Iron; Iron overload; Laboratories, hospital; Quality improvement; Transferrin Abstract Serum iron levels vary throughout the day. Morning levels are generally assumed to be higher than afternoon or evening levels. We studied whether our practice of restricting serum iron collections to the morning was necessary. Serum iron, iron-binding capacity, transferrin saturation, and ferritin levels were determined on blood specimens obtained from 2 healthy adult volunteers at, noon, and (day 1) and (day 2). Although statistically significant differences among mean values for the collection times were observed for iron, iron-binding capacity, and (log) ferritin, no consistent diurnal variation was seen. Morning iron levels were higher than afternoon levels for only half of the subjects. Between-day variation for all 4 analytes was similar to within-day variation. We conclude that the practice of restricting iron specimen collections to a specific time of day does not improve the reliability of the test result. Serum iron, total iron-binding capacity (TIBC), and calculated transferrin saturation (TS) tests are used to screen for and monitor conditions of iron deficiency and iron overload. Although the usefulness of these tests for diagnosing iron deficiency can be debated, 1 they continue to be ordered with some frequency. The tests have proven useful for screening for hereditary hemochromatosis, and, because hemochromatosis is the most common single-gene inherited disorder in whites, many have advocated population-based screening. 2-4 Because we anticipated increased requests for serum iron studies, we reviewed our collection requirements for these analytes. Although the diurnal variation of iron is well documented, published studies offer conflicting conclusions about the pattern of variation. The prevailing opinion is that iron levels are higher in the morning than in the afternoon or evening. 5,6 However, some studies have shown iron levels to be higher in the afternoon or evening than in the morning, 7,8 and other studies have found significant variation but no systematic trend. 9,1 Our laboratory s iron reference range is based on specimens obtained in the morning. When we receive a request for an afternoon or evening test of iron levels for the investigation of iron deficiency, we contact the ordering physician, explain that afternoon or evening levels may be misleading, and suggest a ferritin level as an alternative test. Striving to streamline our processes, we questioned whether this practice, which introduces delays in specimen collection and interrupts the physicians, is necessary. Because many published studies were conducted a number of years ago and did not use state-of-the-art methods, we investigated the effect of time of day on iron, TIBC, TS, and ferritin levels. 82 Am J Clin Pathol 22;117:82-88 American Society for Clinical Pathology Downloaded from on 18 August 218
2 Clinical Chemistry / ORIGINAL ARTICLE Materials and Methods Twenty healthy, white, adult volunteer subjects (18 women, 2 men), ranging in age from 29 to 45 years (mean, 38 years), participated in this study. Eighteen subjects worked the day shift, 1 worked from noon to 8 PM, and 1 worked the evening shift. No subjects were blood donors or had ingested iron-containing supplements within 48 hours of blood specimen collection; none of the women were menstruating during the study. All subjects were seated for 1 minutes before collection. Tourniquets were used and remained in place for the duration of the collection. All collections were completed in less than 2 minutes. A 7-mL plain evacuated tube (Monoject, Sherwood Medical, St Louis, MO) was used to collect blood at, noon, and on day 1 and at on day 2 for iron, TIBC, TS, and ferritin determinations. Both specimens were obtained after an overnight fast, and all subjects were fasting for at least 2 hours before collection of the noon and specimens. Specimens from day 1 were refrigerated before analysis on day 2. For each subject, specimens from the 4 collection times were analyzed on the same run for each analyte. Iron levels were determined by FerroZine-iron complex spectrophotometry on a Hitachi Chemistry Analyzer (Roche Diagnostics, Indianapolis, IN). In our laboratory, the iron reference range is 5 to 15 µg/dl ( µmol/l) for men and 35 to 145 µg/dl ( µmol/l) for women. TIBC was determined on the Hitachi Chemistry Analyzer by the automated determination of unbound ironbinding capacity using the FerroZine-iron complex method. TIBC equals unbound iron-binding capacity plus serum iron. The TIBC reference range is 25 to 4 µg/dl ( µmol/l). TS is calculated as follows: (iron TIBC) 1. The TS reference range is 14% to 5%. Ferritin was determined on a Bayer ACS: 18 Analyzer (Bayer, Tarrytown, NY) by a 2-site chemiluminometric sandwich immunoassay. The ferritin reference range is 2 to 3 ng/ml (2-3 µg/l) for men and 2 to 2 ng/ml (2-2 µg/l) for women. Within-run and between-run precision are shown in Table 1. The data from specimen collections at the 4 time points were analyzed separately for iron, TIBC, TS, and (log-transformed) ferritin values using a repeated measures analysis of variance with an unstructured variance-covariance specification. Log-transformed values were used for statistical analysis of ferritin results because of the skewed distribution of results. The results for ferritin, however, are summarized in the original units scale. Specific contrasts (eg, vs 4 PM) were tested at an adjusted alpha level (alpha =.17; ie, for 3 pairwise comparisons) if the overall repeated measures effect (collection time) was significant at an alpha level of.5. A descriptive assessment of the within-subject variation (within-day vs between-day) was summarized based on the within-subject pairwise deltas (ie, noon-, -, and day 1- day 2). The study was approved by the institutional review board of the Mayo Foundation. Results The means (SDs) for each test result for blood drawn at, noon, and on day 1 and at on day 2, respectively, were as follows: iron, 9 (37) µg/dl (16.1 [6.6] µmol/l), 98 (36) µg/dl (17.5 [6.4] µmol/l), 93 (43) µg/dl (16.6 [7.7] µmol/l), and 95 (32) µg/dl (17. [5.7] µmol/l); TIBC, 335 (43) µg/dl (6. [7.7] µmol/l), 348 (42) µg/dl (62.3 [7.5] µmol/l), 346 (41) µg/dl (61.9 [7.3] µmol/l), and 336 (45) µg/dl (6.1 [8.1] µmol/l); TS, 27.3% (11.8%), 28.4% (1.9%), 27.1% (12.3%), and 28.7% (1.7%); and ferritin, 38.1 (38.) ng/ml (38.1 [38.] µg/l), 38.8 (38.2) ng/ml (38.8 [38.2] µg/l), 36.8 (35.8) ng/ml (36.8 [35.8] µg/l), and 38.4 (37.7) ng/ml (38.4 [37.7] µg/l). Distributions for each of these analytes are shown in Figure 1. Table 2 shows the overall mean differences (and 95% confidence intervals) between on day 1 and noon and 4 PM on day 1 and on day 2. Overall, significant differences among mean values for the various collection times were observed for iron (P =.1), TIBC (P <.1), and (log) Table 1 Analytic Precision Within-Run Precision Between-Run Precision Analyte CV, % Pool Mean CV, % Pool Mean Iron, µg/dl (µmol/l) (21.7) (21.3) (45.6) (45.1) TIBC, µg/dl (µmol/l) (14.5) (19.3) (38.8) (22.9) Ferritin, ng/ml (µg/l) (46) (49) (4) (41) CV, coefficient of variation; TIBC, total iron-binding capacity. American Society for Clinical Pathology Am J Clin Pathol 22;117: Downloaded from on 18 August 218
3 Dale et al / DIURNAL VARIATION OF SERUM IRON LEVELS A B Serum Iron (µmol/l) Iron-Binding Capacity (µmol/l) C D 8 2 Transferrin Saturation (%) Ferritin (µg/l) Figure 1 Distribution of results for analyses of blood collected at 4 times. Box plots display minimal, 5th percentile, 5th percentile, 95th percentile, and maximal levels. A, Serum iron. B, Total iron-binding capacity. C, Transferrin saturation. D, Ferritin. Values are given as Système International units. To convert µmol/l to conventional units (µg/dl) for iron and iron-binding capacity, divide by.179. To determine conventional units for ferritin (ng/ml), divide by 1.. The percentage for transferrin saturation remains the same. ferritin (P =.3). Concordance among values at the 4 collection times is shown in Figure 2. Significant pairwise differences (eg, -) were noted for both noon vs and vs for TIBC. No significant pairwise differences were seen for iron, TS, or (log) ferritin. Accordingly, the within-day and between-day differences for iron, TS, and (log) ferritin were not statistically significant. The intraindividual differences observed are shown in Figure 3. For individual subjects, iron levels at noon on day 1, on day 1, and on day 2 ranged from 25%, 54%, and 42% lower to 63%, 11%, and 17% higher than levels on day 1, respectively. The between-day iron difference was greater than the within-day difference in 13 subjects (65%). No consistent pattern of change was seen. In 1 subjects, morning iron levels were higher than noon or 4 PM levels; in the remaining 1 subjects, noon or iron levels were higher than morning levels. One subject had subnormal iron levels; iron levels collected at each of the 4 time points were below our reference range. TIBC levels for samples collected at noon on day 1, 4 PM on day 1, and on day 2 ranged from 3%, 4%, and 12% lower to 2%, 13%, and 9% higher than levels on 84 Am J Clin Pathol 22;117:82-88 American Society for Clinical Pathology Downloaded from on 18 August 218
4 Clinical Chemistry / ORIGINAL ARTICLE Table 2 Mean Within-Day and Between-Day Differences (95% Confidence Intervals) Compared With, * Analyte/ Collection Time Conventional Units SI Units Iron, day ( 17.6 to 2.4) 1.4 ( 3.2 to.4), day ( 22.6 to 16.9).5 ( 4. to 3.), day ( 18.7 to 1.2).8 ( 3.3 to 1.8) TIBC, day ( 2.2 to 5.) 2.3 ( 3.6 to.9), day ( 17.1 to 4.5) 1.9 ( 3.1 to.8), day 2.8 ( 8. to 6.5).1 ( 1.4 to 1.2) TS, day ( 4. to 1.8) 1.1 ( 4. to 1.8), day 1.2 ( 5.3 to 5.7).2 ( 5.3 to 5.7), day ( 5.7 to 2.9) 1.4 ( 5.7 to 2.9) Ferritin, day 1.7 ( 1.7 to.3).7 ( 1.7 to.3), day (.6 to 3.2) 1.3 (.6 to 3.2), day 2.3 ( 1.7 to 1.1).3 ( 1.7 to 1.1) TIBC, total iron-binding capacity; TS, transferrin saturation. * Conventional units of measure are as follows: iron and TIBC, µg/dl; TS, %; ferritin, ng/ml. Système International (SI) units of measure are as follows: iron and TIBC, µmol/l; ferritin, µg/l (the percentage for transferrin saturation remains the same). P <.5. Confidence intervals for ferritin are based on observed data, not a log-transformed scale. Other confidence intervals are based on the results of repeated measures analysis of variance. day 1, respectively. The between-day TIBC difference was greater than the within-day difference in 7 subjects (35%). TS levels for samples collected at noon on day 1, on day 1, and on day 2 ranged from 27%, 56%, and 41% lower to 57%, 15%, and 135% higher than levels on day 1, respectively. The between-day TS difference was greater than the within-day difference in 11 subjects (55%). Ferritin levels for samples collected at noon on day 1, on day 1, and on day 2 ranged from 11%, 23%, and 22% lower to 14%, 13%, and 33% higher than levels on day 1, respectively. The between-day ferritin difference was greater than the within-day difference in 15 subjects (75%). Ferritin levels were subnormal in 1 subject and mildly elevated in another subject; for both subjects, ferritin levels collected at each of the 4 time points were abnormal. Discussion In the past at our institution, blood samples for routine laboratory testing typically were obtained in the morning and analyzed in batches, and the results were reported in the afternoon. Most reference values were determined based on an overnight fast and morning sample collection. Random access instrumentation now allows continuous analysis and reporting throughout the day. This improvement makes it possible for specimens to be obtained at times more convenient to patients and for physician appointments to be more frequent and efficient. However, interpretation of test results for analytes with significant diurnal variation may be problematic if collection times change. As a part of a quality improvement initiative in our laboratory, we critically evaluated our patient preparation and specimen collection practices. In this study of the effect of specimen collection time on results for various indicators (iron, TIBC, TS, and ferritin concentrations) used to screen for iron status, we found no consistent diurnal pattern of iron and TS diurnal variation for any of them. For more than half of the subjects, the between-day change was greater than the within-day change for both iron and TS. In some subjects, between-day changes greater than 1% were observed for both iron and TS. Therefore, we conclude that restricting iron and TS collections to a particular time of day does not improve the reliability of the result. Our study has several limitations. First, we included only healthy subjects in our evaluation. However, Heilmann 11 showed that the diurnal pattern seen in patients with iron deficiency was similar to the pattern seen in healthy subjects. Furthermore, earlier studies showed that transferrin saturation measurements remain diagnostically abnormal throughout the day in patients with hemochromatosis Second, because most of our subjects were women, differences between sexes were not assessed. However, earlier diurnal variation studies did not demonstrate differences between men and women. 5,8,9 Third, we did not study repeated 24-hour cycles to determine whether patterns demonstrated by each subject were consistently repeated over time. Bowie et al 9 found that the iron level ranged from 86 to 2 µg/dl ( µmol/l) for 1 subject during a 3-day fast. The subject s pattern seemed cyclic, but over a 48-hour period rather than a 24-hour period, with levels rising from the morning of day 1 to the morning of day 2 and then falling to the morning of day 3. Finally, our sample size was relatively small. Larger studies are needed to confirm the findings of these studies. The within-day and between-day variations in iron levels seen in our study are well documented and limit the diagnostic usefulness of iron measurements. 1,15 Although the diurnal variation seems unpredictable and may be outside the laboratory s control, control of dietary factors may reduce iron variability. Statland et al 16 reported a statistically significant increase in the iron level 2 hours after subjects had eaten. Lammi-Keefe et al 17 demonstrated a reduction in the between-day iron coefficient of variation from 26.1% to 16.6% after fasting. In our study, the variability seen in specimens obtained at noon and (at least a 2-hour fast) was not significantly greater than the variability seen in 2 fasting collections. When TS is used to screen for hemochromatosis, the fasting state has been shown to decrease the number of American Society for Clinical Pathology Am J Clin Pathol 22;117: Downloaded from on 18 August 218
5 Dale et al / DIURNAL VARIATION OF SERUM IRON LEVELS A B Serum Iron (µmol/l), Total Iron-Binding Capacity (µmol/l), C D Transferrin Saturation (%), Ferritin (µg/l), Figure 2 Concordance among values at 4 collection times. x, on day 1; y, noon on day 1 (closed circle), on day 1 (open circle), or on day 2 (square). A, Serum iron. B, Total iron-binding capacity. C, Transferrin saturation. D, Ferritin. To convert µmol/l to conventional units (µg/dl) for iron and iron-binding capacity, divide by.179. To determine conventional units for ferritin (ng/ml), divide by 1.. The percentage for transferrin saturation remains the same. false-positive TS screens. 18 Published screening algorithms recommend repeated testing on a fasting specimen if the initial screen is abnormal. 19,2 Others have reported that diet has little effect on iron levels. 8,14 Avoidance of iron-containing supplements before specimen collection also may reduce intraindividual variability of iron levels and yield a more accurate reflection of iron status. When a small dose of iron was ingested in an iron tolerance test, iron levels were increased over the baseline for at least 8 hours, with significantly greater changes observed in iron-deficient subjects compared with ironreplete subjects. 21,22 A similar study using iron-fortified foods found the effect to be lower and more delayed. 21 Currently, to minimize changes caused by the recent ingestion of iron, we recommend that iron-containing supplements be discontinued 24 hours before the collection of blood specimens for determination of iron levels. However, the minimal time needed to eliminate food and iron-supplementation effects is not yet established. When iron is used to screen for or monitor iron deficiency or overload, several measurements are needed. 9 Lammi-Keefe et al 17 found that accurate assessment of iron status required 3 testing cycles in healthy women and 8 cycles in elderly women with rheumatoid arthritis. Economic concerns and health care payer rules for frequency of testing make multiple cycles of testing for a single diagnosis undesirable. For iron deficiency, ferritin has been shown to be the best single test. 1,23,24 In our study, between-day variations of ferritin were smaller than those of iron and TS. After completing our study, despite finding that the time of day was not critical, we decided that the opportunity to convert orders from iron to ferritin justified the time spent contacting 86 Am J Clin Pathol 22;117:82-88 American Society for Clinical Pathology Downloaded from on 18 August 218
6 Clinical Chemistry / ORIGINAL ARTICLE A 12 1 B Serum Iron, % Change From (8.4) (3.2) (4.7) Iron-Binding Capacity, % Change From (3.8) (3.2) (.2) C 16 D 14 Transferrin Saturation, % Change From (4.) (.5) (5.2) Ferritin, % Change From (1.8) ( 3.4) (.8) Figure 3 Intraindividual differences between results of analysis on blood collected at on day 1 and those for blood collected at 3 other times. The mean percentage difference is shown in parentheses. A, Serum iron. B, Total iron-binding capacity. C, Transferrin saturation. D, Ferritin. the physician. A more direct approach such as that taken by laboratories in Ottawa (ie, determining only the ferritin level if iron, TIBC, and ferritin were ordered) resulted in an 8% reduction in iron and TIBC tests performed. 25 In our setting, we have chosen to maintain physician choice. In the future, we hope to include ordering and patient preparation recommendations in our electronic order system as a way to educate physicians and improve test-ordering practices. Conclusions Although overall statistically significant differences among the collection times were observed for iron, TIBC, and (log) ferritin, no consistent diurnal variation pattern was seen. For half of the subjects, morning iron levels were higher than afternoon iron levels; for the remaining half, the reverse was true. For all 4 analytes, the relative magnitude of the between-day variation was similar to the relative magnitude of the within-day variation. The practice of restricting blood collection for iron determination to a specific time of day does not improve the reliability of the result. From the 1 Division of Clinical Biochemistry and Immunology and the 2 Section of Biostatistics, Mayo Clinic, Rochester, MN. Address correspondence to Dr Dale: Mayo Clinic, 2 First St SW, Rochester, MN Acknowledgments: We thank Melissa M. Ward for participation in this study and Constance L. Center for efforts in manuscript preparation. American Society for Clinical Pathology Am J Clin Pathol 22;117: Downloaded from on 18 August 218
7 Dale et al / DIURNAL VARIATION OF SERUM IRON LEVELS References 1. Guyatt GH, Oxman AD, Ali M, et al. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med. 1992;7: Phatak PD, Guzman G, Woll JE, et al. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med. 1994;154: Balan V, Baldus W, Fairbanks V, et al. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology. 1994;17: Adams PC, Gregor JC, Kertesz AE, et al. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 3-year database. Gastroenterology. 1995;19: Hoyer K. Physiologic variations in the iron content of human blood serum. Acta Med Scand. 1944;119: Hamilton LD, Gubler CJ, Cartwright GE, et al. Diurnal variation in plasma iron level of man. Proc Soc Exp Biol Med. 195;75: Statland BE, Winkel P, Bokelund H. Variation of serum iron concentration in young healthy men: within-day and day-today changes. Clin Biochem. 1976;9: Wiltink WF, Kruithof J, Mol C, et al. Diurnal and nocturnal variations of the serum iron in normal subjects. Clin Chim Acta. 1973;49: Bowie EJ, Tauxe WN, Sjobergew JR, et al. Daily variation in the concentration of iron in serum. Am J Clin Pathol. 1963;4: Costongs GM, Janson PC, Bas BM, et al. Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem. 1985;23: Heilmann E. Daily fluctuations of serum iron level and iron binding capacity in various diseases [in German]. Med Klin. 1973;68: Edwards CQ, Griffen LM, Kaplan J, et al. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med. 1989;226: Speck B. The daily variations in serum iron and latent iron binding capacity in hepatitis, liver cirrhosis, alcoholism, hemochromatosis and aplastic anemia [in German]. Schweiz Med Wochenschr. 197;1: Sinniah R, Doggart JR, Neill DW. Diurnal variations of the serum iron in normal subjects and in patients with haemochromatosis. Br J Haematol. 1969;17: Statland BE, Winkel P. Relationship of day-to-day variation of serum iron concentrations to iron-binding capacity in healthy young women. Am J Clin Pathol. 1977;67: Statland BE, Winkel P, Bokelund H. Factors contributing to intra-individual variation of serum constituents, 2: effects of exercise and diet on variation of serum constituents in healthy subjects. Clin Chem. 1973;19: Lammi-Keefe CJ, Lickteig ES, Ahluwalia N, et al. Day-to-day variation in iron status indexes is similar for most measures in elderly women with and without rheumatoid arthritis. J Am Diet Assoc. 1996;96: Edwards CQ, Carroll M, Bray P, et al. Hereditary hemochromatosis: diagnosis in siblings and children. N Engl J Med. 1977;297: Witte DL, Crosby WH, Edwards CQ, et al. Practice guideline development task force of the College of American Pathologists: hereditary hemochromatosis. Clin Chim Acta. 1996;245: Phatak PD, Cappuccio JD. Management of hereditary hemochromatosis. Blood Rev. 1994;8: Crosby WH, O Neil-Cutting MA. A small-dose iron tolerance test as an indicator of mild iron deficiency. JAMA. 1984;251: Ekenved G, Norrby A, Solvell L. Serum iron increase as a measure of iron absorption: studies on the correlation with total absorption. Scand J Haematol Suppl. 1976;28: Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;29: Barron BA, Hoyer JD, Tefferi A. A bone marrow report of absent stainable iron is not diagnostic of iron deficiency. Ann Hematol. 21;8: van Walraven C, Goel V, Chan B. Effect of population-based interventions on laboratory utilization: a time-series analysis. JAMA. 1998;28: Am J Clin Pathol 22;117:82-88 American Society for Clinical Pathology Downloaded from on 18 August 218
Paediatrica Indonesiana. Using iron profiles to identify anemia of chronic disease in anemic children with tuberculosis
Paediatrica Indonesiana VOLUME 51 July NUMBER 4 Original Article Using iron profiles to identify anemia of chronic disease in anemic children with tuberculosis Reni Wigati, Endang Windiastuti, Badriul
More informationUrine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples
Immunopathology / Electrophoresis of Unconcentrated Urine Samples Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples Anja C. Roden, MD,
More informationQuantitative Determination Of Serum Iron, Unsaturated Iron Binding Capacity (UIBC), And Total Iron Binding Capacity (TIBC)
Quantitative Determination Of Serum Iron, Unsaturated Iron Binding Capacity (UIBC), And Total Iron Binding Capacity (TIBC) Objectives To Determine The Normal Level Of Serum Iron. To Determine The Use Of
More informationUniversity Journal of Pre and Para Clinical Sciences
ISSN 2455 2879 Volume 2 Issue 4 2016 SERUM FERRITIN AND ITS BIOLOGICAL VARIATION IN HEALTHY ADULT MALES RAJALAKSHMI K Department of Biochemistry, KILPAUK MEDICAL COLLEGE AND HOSPITAL Abstract : Iron Deficiency
More informationH-ferritin (Human) ELISA Kit
H-ferritin (Human) ELISA Kit Catalog Number KA0211 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of
More informationFER PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Ferritin REF 447160 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by:
More informationIron Status Assessment <DUE: 5/15/14>
Iron Status Assessment Note: Clinical values are reported to one decimal place; please report your final calculations accordingly (HgB, Hct, MCV, MCH, MCHC). Must show calculations and units
More informationChemistry. Clinical Chemistry 43: (1997) General Clinical
Clinical Chemistry 43:12 2413 2417 (1997) General Clinical Chemistry Fully automated measurement of total iron-binding capacity in serum Hachiro Yamanishi, * Shigeki Kimura, Shigeru Iyama, Yoshihisa Yamaguchi,
More informationTest Name Results Units Bio. Ref. Interval. Packed Cell Volume (PCV) %
Lab No Mr DUMMY-----Z289 LLT12448 Age 15 Years Gender 16/4/2018 22600M 16/4/2018 23529M 27/6/2018 73049M Ref By Test Results Units Bio Ref Interval ANEMIA ANEL 1 COMLETE BLOOD COUNT (CBC) (Electrical Impedance
More informationCHEMILUMINESCENCE ENZYME IMMUNOASSAY (CLIA) THYROID STIMULATING HORMONE (FERRITIN) Ferritin
DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and 116, Woodland hills CA 91367 USA Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com
More informationReference values for oral iron absorption of bivalent iron in healthy volunteers
Published 22 January 2015, doi:10.4414/smw.2015.14063 Cite this as: Reference values for oral iron absorption of bivalent iron in healthy volunteers Korinna Klöpfer a, Pirmin Schmid a, Walter A. Wuillemin
More informationFor In Vitro Diagnostic Use
SYNCHRON System(s) Chemistry Information Sheet Lactate Dehydrogenase REF 442660 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED USE reagent, when used in
More informationSCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
1 SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY PBL SEMINAR: IRON AND IRON BALANCE An Overview What are some of the vital functions
More informationJ of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 19/May 12, 2014 Page 5083
CORRELATION STUDY BETWEEN BONE MARROW IRON AND SERUM IRON AND SERUM FERRITIN IN PATIENTS OF MODERATE TO SEVERE ANEMIA Ankita Tripathi 1, R. K. Nigam 2, Reeni Malik 3, P. Jain 4, Atul Shrivastava 5 HOW
More informationSuccessful performance in proficiency testing (PT) is required
Performance Characteristics of Several Rules for Self-interpretation of Proficiency Testing Data R. Neill Carey, PhD; George S. Cembrowski, MD; Carl C. Garber, PhD; Zohreh Zaki, MD Context. Proficiency
More informationDRG International, Inc., USA Fax: (908)
NAME AND INTENDED USE Ferritin is an indirect solid phase enzyme immunoassay (ELISA) for the quantitative measurement of Ferritin in human serum or plasma. The assay is intended for in vitro diagnostic
More informationHuman Ferritin ELISA Kit Protocol. (Cat. No.:EK )
Human Ferritin ELISA Kit Protocol (Cat. No.:EK-310-25) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com INTENDED USE For the quantitative
More informationM-TP PRINCIPLE REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Microprotein REF 445860 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED
More informationWhat Are We Gonna Do About It?
What Have We Learned About Donor Iron Stores and What Are We Gonna Do About It? Barbara J. Bryant, MD Professor and Vice Chair, Pathology Medical Director, UTMB Transfusion Service Disclosures PI on
More informationSRM 2921 reference material for ctni: Lights and Shadows November 30, 2011
SRM 2921 reference material for ctni: Lights and Shadows November 30, 2011 Robert H. Christenson, Ph.D., DABCC, FACB University of Maryland School of Medicine University of Maryland Medical Center Baltimore,
More informationIs serum ferritin a sufficient marker for evaluating and monitoring treatment of iron overload?
2 nd World Congress on Controversies in Hematology (COHEM) Barcelona, September 6 8, 2012 Is serum ferritin a sufficient marker for evaluating and monitoring treatment of iron overload? Antonio Piga Thalassemia
More informationSERUM FERRITIN AS THE MOST SENSITIVE MEASURE OF IRON STORES IN PREGNANT WOMEN
SERUM FERRITIN AS THE MOST SENSITIVE MEASURE OF IRON STORES IN PREGNANT WOMEN Abstract Pages with reference to book, From 185 To 187 Hamid Javaid Qureshi ( Department of Physiology, Rawalpindi Medical
More informationSerum Ferritin Iron, a New Test, Measures Human Body Iron Stores Unconfounded by Inflammation
Serum Ferritin Iron, a New Test, Measures Human Body Iron Stores Unconfounded by Inflammation VICTOR HERBERT, a ELIZABETH JAYATILLEKE, a SPENCER SHAW, a ALAN S. ROSMAN, a PATRICIA GIARDINA, b ROBERT W.
More informationInt.J.Curr.Res.Aca.Rev.2016; 4(4):
International Journal of Current Research and Academic Review ISSN: 2347-3215 Volume 4 Number 4 (April-2016) pp. 180-184 Journal home page: http://www.ijcrar.com doi: http://dx.doi.org/10.20546/ijcrar.2016.404.022
More informationAAG PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Alpha 1 -Acid Glycoprotein REF 447780 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by:
More informationMetabolic Liver Diseases (for the Boards)
Metabolic Liver Diseases (for the Boards) HH Iron dysregulation (understand the factors involved) Multisystem (which systems?) Diagnostic Lab Studies and key stains? Complications Wilson s Copper dysregulation
More informationQUANTITATIVE DETERMINATION OF HUMAN EPIDIDYMIS PROTEIN 4
QUANTITATIVE DETERMINATION OF HUMAN EPIDIDYMIS PROTEIN 4 NEW PRODUCT Human Epididymis Protein 4 () ELISA High sensitivity (0.15 pmol/l) Excellent analytical characteristics Validated for human serum samples,
More informationMitigating Iron Deficiency in Blood Donors: Issues, Strategies, and Prevention
Mitigating Iron Deficiency in Blood Donors: Issues, Strategies, and Prevention Barbara J. Bryant, MD Professor and Vice Chair, Pathology Medical Director, UTMB Transfusion Service Galveston, Texas Disclosures
More informationBiological Variations of Leukocyte Numerical and Morphologic Parameters Determined by UniCel DxH 800 Hematology Analyzer
Biological Variations of Leukocyte Numerical and Morphologic Parameters Determined by UniCel DxH 800 Hematology Analyzer Huqiang Tang, MS, MPH; Jiyong Jing, MS; Dandan Bo, BS; Dongsheng Xu, MD, PhD N Context.
More informationDate. Albumin measurements are used in the diagnosis and treatment of numerous diseases primarily involving the liver and/or kidneys.
SYNCHRON System(s) Chemistry Information Sheet Copyright 2013 Beckman Coulter, Inc. Albumin REF 442765 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by Date Reviewed by Date PRINCIPLE INTENDED USE
More informationAFP (Human) CLIA Kit. Catalog Number KA assays Version: 02. Intended for research use only.
AFP (Human) CLIA Kit Catalog Number KA2804 96 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...
More informationPDGFRB FISH PRODUCT DATASHEET. Proprietary Name: PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD)
PDGFRB FISH PRODUCT DATASHEET Proprietary Name: PDGFRB FISH for Gleevec Eligibility in Myelodysplastic Syndrome/Myeloproliferative Disease (MDS/MPD) Established Name: PDGFRB FISH for Gleevec in MDS/MPD
More informationAAT PRINCIPLE SPECIMEN. REF (150 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Alpha 1 -Antitrypsin REF 447740 (150 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed
More informationDate. Alkaline phosphatase measurements are used in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases.
SYNCHRON CX System(s) Chemistry Information Sheet Copyright 2008 Beckman Coulter, Inc. Alkaline Phosphatase Kit Reorder # 442670 (200 tests/cartridge) Kit Reorder # 476821 (400 tests/cartridge) For In
More informationIron Regulation Gone Wrong
Iron Regulation Gone Wrong Stephanie Blackburn, MHS, MLS(ASCP) CM Objectives Describe the function of proteins involved in iron regulation. Explain the development of iron deficiency. Evaluate cases involving
More informationLaboratory Procedure Manual
Laboratory Procedure Manual Analyte: Matrix: Method: Total Iron Binding Capacity (TIBC) Serum Beckman Synchron LX20 Method No.: Revised: as performed by: Collaborative Laboratory Services Ottumwa, Iowa
More informationFreelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies
Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies Montgomery Lobe, MD, and Donald Pasquale, MD Abstract Monoclonal gammopathies are characterized by production of monoclonal
More informationAssessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs Population
Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol 36, no. 2, 2006 157 Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs
More informationEpoetin alfa. Epogen, Procrit (epoetin alfa), Retacrit (epoetin alfa epbx) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.06 Subject: Epoetin alfa Page: 1 of 8 Last Review Date: September 20, 2018 Epoetin alfa Description
More informationAFP (Human) ELISA Kit
AFP (Human) ELISA Kit Catalog Number KA0202 96 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...
More informationCIRME: ten yearsafter. Prof Mauro Panteghini CIRME Scientific Coordinator
CIRME: ten yearsafter Prof Mauro Panteghini CIRME Scientific Coordinator Research Centre for Metrological Traceability in Laboratory Medicine (CIRME) created on 2006with the scope to join in a sole entity
More informationHarmonization of red blood cell distribution width (RDW): an attainable target?
Original Article Page 1 of 5 Harmonization of red blood cell distribution width (RDW): an attainable target? Giuseppe Lippi 1, Silvia Pipitone 2, Emmanuel J. Favaloro 3,4 1 Section of Clinical Biochemistry,
More informationTotal Analytic Error From Concept to Application
Página 1 de 5 Clinical Laboratory News Subscribe CLN Daily CLN Stat CLN Articles Total Analytic Error From Concept to Application Author: James O. Westgard, PhD, and Sten A. Westgard, MS // Date: SEP.1.2013
More informationIron metabolism. And. Anemia in chronic kidney disease
Iron metabolism And Anemia in chronic kidney disease Chittima Sirijerachai Iron distribution Intracellular iron Intracellular ferrous iron Heme iron compound : Hb, myoglobin Iron containing enzyme Intracellular
More informationIron Deficiency Anemia F I R S T Y E A R H E M A T O L O G Y M O D U L E
Iron Deficiency Anemia F I R S T Y E A R H E M A T O L O G Y M O D U L E 2 0 1 3 Objectives By The end of this lecture, the student will be able to: describe briefly iron metabolism in human body. mention
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: Cambridge RGC Approved: September 2012
More informationBiologic Variation of Common Hematologic Laboratory Quantities in the Elderly
Biologic Variation of Common Hematologic Laboratory Quantities in the Elderly CALLUM G. FRASER, PH.D., F.A.A.C.B., STEPHEN P. WILKINSON, M.B., M.R.C.P., RONALD G. NEVILLE, M.R.C.P.G., D.R.C.O.G., JAMES
More informationValuation of Lost Productivity (VOLP) questionnaire and outcomes. The paid work productivity loss obtained from the VOLP included three components: 1)
APPENDIX. ADDITIONAL METHODS AND RESULTS Valuation of Lost Productivity (VOLP) questionnaire and outcomes The paid work productivity loss obtained from the VOLP included three components: 1) absenteeism:
More informationReady, Set, Test! AACC Conference Mass Spectrometry in the Clinical Lab: Best Practice and Current Applications September 17-18, 2013 St.
Ready, Set, Test! Ross Molinaro, PhD, MLS(ASCP) CM, DABCC, FACB Medical Director, Clinical Laboratories Emory University Hospital Midtown Emory Clinical Translational Research Laboratory AACC Conference
More informationWAIT! Ready, Set, Test! Financial Disclosure. Research/Educational grants/consulting/salary support
Ready, Set, Test! Ross Molinaro, PhD, MLS(ASCP) CM, DABCC, FACB Medical Director, Clinical Laboratories Emory University Hospital Midtown Emory Clinical Translational Research Laboratory AACC Conference
More informationHELICA BIOSYSTEMS, INC. HIGH SENSITIVITY HUMAN C-REACTIVE PROTEIN FOR RESEARCH USE ONLY (Not for in vitro diagnostic use)
INTENDED USE HELICA BIOSYSTEMS, INC. HIGH SENSITIVITY HUMAN C-REACTIVE PROTEIN FOR RESEARCH USE ONLY (Not for in vitro diagnostic use) The Helica C-reactive protein assay is intended for the detection
More informationPRINCIPLE. REF (200 tests/cartridge) REF (300 tests/cartridge) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. LD Lactate Dehydrogenase REF 442655 (200 tests/cartridge) REF 476841 (300 tests/cartridge) For In Vitro Diagnostic Use
More informationAPB PRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Apolipoprotein B REF 447730 (300 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed
More informationBlood Donor Iron Status From Research to Policy. Sheila O Brien Alberta Vein to Vein Conference March 19, 2016
Blood Donor Iron Status From Research to Policy Sheila O Brien Alberta Vein to Vein Conference March 19, 2016 Objectives To describe background relating to blood donation and iron To describe current research
More informationPRINCIPLE SPECIMEN. REF (300 tests) ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
IMMAGE Immunochemistry Systems Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Complement REF 446450 (300 tests) For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by:
More information510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE A. 510(k) Number: k100499 B. Purpose for Submission: New Device C. Measurand: Rheumatoid Factors IgG, IgM and IgA and Rheumatoid
More informationEDUCATIONAL COMMENTARY STRAIGHT TALK ABOUT THE D-DIMER
EDUCATIONAL COMMENTARY STRAIGHT TALK ABOUT THE D-DIMER Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits
More informationStability of Plasma for Add-On PT and APTT Tests
COAGULATION AND TRANSFUSION MEDICINE Original Article Stability of Plasma for Add-On PT and APTT Tests DEMETRA NEOFOTISTOS, MT, MARIA OROPEZA, MT(ASCP), AND CHUNG-HSIN TS'AO, PhD We conducted studies to
More information35% of elements in the planet. In rock, found oxidised as haematite or magnetite
35% of elements in the planet In rock, found oxidised as haematite or magnetite Iron sulphur clusters may have been central to the earliest life forms 3.5 billion years ago Bacterial membranes are minature
More informationPreanalytical Variables in Blood Collection: Impact on Precision Medicine
Preanalytical Variables in Blood Collection: Impact on Precision Medicine Carolyn Compton, MD, PhD Chair, Scientific Advisory Committee, Indivumed GmbH Professor of Life Sciences, ASU Professor of Laboratory
More information2009 LAP Audioconference Series. Simple Tests, Tough Problems Patient Care and Laboratory Inspection in Coagulation
2009 LAP Audioconference Series Simple Tests, Tough Problems Patient Care and Laboratory Objectives: After participating in this session, you will be able to: to describe patient care and accreditation
More informationDate. Alkaline phosphatase measurements are used in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases.
SYNCHRON System(s) Chemistry Information Sheet Copyright 2013 Beckman Coulter, Inc. Alkaline Phosphatase REF 442670 (200 tests/cartridge) REF 476821 (400 tests/cartridge) For In Vitro Diagnostic Use ANNUAL
More informationALT PRINCIPLE. REF (200 tests/cartridge) REF (400 tests/cartridge) ANNUAL REVIEW Reviewed by: Date.
SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Alanine Aminotransferase REF 442620 (200 tests/cartridge) REF 476826 (400 tests/cartridge) For In Vitro Diagnostic Use
More informationIRON METABOLISM. IRON STORES IN MAN AS MEASURED
RON METABOLSM. RON STORES N MAN AS MEASURED BY PHLEBOTOMY' By DONALD HASKNS,2 ALEXANDER R. STEVENS, JR.,8 STUART FNCH,2 AND CLEMENT A. FNCH 4 (From the Department of Medicine, University of Washington
More informationCyfra 21-1 IRMA. Product information Information about other products is available at: Userś Manual DE52100
Product information Information about other products is available at: www.demeditec.com Userś Manual Cyfra 21-1 IRMA The CYFRA 21.1 IRMA system provides a direct in vitro quantitative determination of
More informationImproving Quality and Turnaround Time of Clinical Chemistry Specimens Using Plasma
Improving Quality and Turnaround Time of Clinical Chemistry Specimens Using Plasma April 20, 2017 Sol Green PhD FACB Director of Medical Affair BD Life Science Preanalytical Systems Clinical Professor
More informationIron Deficiency Anemia
Diagnosis of Iron Deficiency Anemia Using the Abaxis VetScan HM2 Hematology System Contributing Authors: Mary Anna Thrall, BA, DVM, MS, DACVP; Barton Gillespie, BS, DVM Ross University School of Veterinary
More informationActa Medica Okayama. Iron metabolism of in-testinal mucosa in various blood diseases JUNE Ikuro Kimura Junichiro Tsuchida Hidenari Kodani
Acta Medica Okayama Volume 18, Issue 3 1964 Article 3 JUNE 1964 Iron metabolism of in-testinal mucosa in various blood diseases Ikuro Kimura Junichiro Tsuchida Hidenari Kodani Okayama University, Okayama
More informationS1725 Method Validation and Verification: Case Studies and Laboratory Challenges
S1725 Method Validation and Verification: Case Studies and Laboratory Challenges James H. Nichols, PhD, D(ABCC) Lauren N. Person, DO, MPH, FCAP Objectives Identify the difference between method validation
More informationFrancesca Di Serio 1, G. Amodio 2, Mario Caputo 3, Martina Zaninotto 4, Cosimo Ottomano 5
Francesca Di Serio 1, G. Amodio 2, Mario Caputo 3, Martina Zaninotto 4, Cosimo Ottomano 5 1 Department of Clinical Pathology I, University Hospital, Bari, Italy 2 Emergency Cardiology Department, University
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Comparative Study of the Efficacy and Tolerability of Carbonyl Iron and Ferrous Sulfate in
More informationDeveloping an LC-MS/MS method for hepcidin quantitative analysis
Developing an LC-MS/MS method for hepcidin quantitative analysis Asian Pacific Conference on Chromatography & Mass Spectrometry 2010 14 January 2010 Alan L. Rockwood and David K. Crockett ARUP Laboratories,
More informationPATIENTS AND HEALTH PROFESSIONALS TOGETHER FOR OPTIMAL CARE
PATIENTS AND HEALTH PROFESSIONALS TOGETHER FOR OPTIMAL CARE Clinical Management of Thalassaemia IRON OVERLOAD Aurelio Maggio IRON OVERLOAD MAIN ISSUES WHICH ARE THE KEY MECHANISMS CAUSING IRON OVERLOAD?
More informationTransferrin Human ELISA Kit
Transferrin Human ELISA Kit Cat. No.:DEIA1523 Pkg.Size:96T Intended use For the quantitative measurement of Human Transferrin concentrations in cel culture supernatants, milk, saliva and urine. General
More informationThe Facts. about Biotin Interference. Ursula Klause, PhD Sr. Scientific Affairs Manager Medical and Scientific Affairs US
The Facts about Biotin Interference Ursula Klause, PhD Sr. Scientific Affairs Manager Medical and Scientific Affairs US 1 Presenter is an employee of Roche Diagnostics within the division of Medical and
More informationAugust Chemistry. Coagulation. Hospital Pathology Associates. Immunology. Microbiology. Referral Testing. Drugs of abuse screen, urine
August 2017 Chemistry Drugs of abuse screen, urine Coagulation APTT reference range change Von Willebrand screen testing lab change Hospital Pathology Associates Dr Erik Jenson joins HPA Immunology Anti-nuclear
More informationSUPPLEMENTARY INFORMATION. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume
SUPPLEMENTARY INFORMATION Common variants in TMPRSS6 are associated with iron status and erythrocyte volume Beben Benyamin, Manuel A. R. Ferreira, Gonneke Willemsen, Scott Gordon, Rita P. S. Middelberg,
More informationMOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS. Richard L. Hodinka, Ph.D.
MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS Richard L. Hodinka, Ph.D. University of South Carolina School of Medicine Greenville Greenville Health System, Greenville, SC hodinka@greenvillemed.sc.edu
More informationSee external label 2 C-8 C Σ=96 tests Cat # SHBG Cat #
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationEfficacy of a home made quality control serum
ecommons@aku Section of Haematology/Oncology Department of Medicine January 1989 Efficacy of a home made quality control serum Rukbsana Lalani Aga Khan University Ayesha Molla Aga Khan University Mohammad
More informationEffect of phytohaemagglutinin in the leucocyte migration inhibition test as a measure of cellmediated immunity
J. clin. Path., 1974, 27, 113-117 Effect of phytohaemagglutinin in the leucocyte migration inhibition test as a measure of cellmediated immunity WARWICK L. MORISON From the Dermatology Department, St Helier
More informationAssayMax Human Transferrin ELISA Kit
AssayMax Human Transferrin ELISA Kit Assaypro LLC 3400 Harry S Truman Blvd St. Charles, MO 63301 T (636) 447-9175 F (636) 395-7419 www.assaypro.com For any questions regarding troubleshooting or performing
More informationResearch Article. Concomitant therapy in clinical trials of drugs: Its role, problems and approaches to its consideration
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2015, 7(3):182-186 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Concomitant therapy in clinical trials of drugs:
More informationFor In Vitro Diagnostic Use
SYNCHRON System(s) Chemistry Information Sheet C-Reactive Protein REF (200 tests/cartridge) 465131 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED USE reagent,
More informationAn automated method for serum magnesium estimation
J. clin. Path. (1964), 17, 644 An automated method for serum magnesium estimation D. N. WHITMORE AND D. I. K. EVANS From the Department of Clinical Pathology, Guy's Hospital, London SYNOPSIS An automated
More informationSupplementary Information
Electronic Supplementary Material (ESI) for Lab on a Chip. This journal is The Royal Society of Chemistry 2016 Supplementary Information Translating Diagnostic Assays from the Laboratory to the Clinic:
More informationFor In Vitro Diagnostic Use. Rx Only. Reviewed by Date Reviewed by Date
SYNCHRON System(s) Chemistry Information Sheet 2015 Beckman Coulter, Inc. All rights reserved. FE Iron 467910 For In Vitro Diagnostic Use ANNUAL REVIEW Rx Only Reviewed by Date Reviewed by Date PRINCIPLE
More informationIRON METABOLISM & CLINICAL IMPORTANCE
Iron IRON METABOLISM & CLINICAL IMPORTANCE IRON METABOLISM LEARNING OBJECTIVES At the end of the lecture, student should be able to; Know the biochemical proper1es of iron Enlist the func1ons of iron in
More informationPAB PRINCIPLE. Kit Reorder # ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
SYNCHRON CX System(s) Chemistry Information Sheet Copyright 2008 Beckman Coulter, Inc. Prealbumin Kit Reorder # 475106 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE
More informationHerpes Simplex 1 IgM (HSV1 IgM)
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationPATHOLOGICAL ASPECTS OF CLINICAL TRIALS. Prof. Dr. med. Christoph Röcken Dept. of Pathology Christian-Albrechts-University Kiel, Germany
PATHOLOGICAL ASPECTS OF CLINICAL TRIALS Prof. Dr. med. Christoph Röcken Dept. of Pathology Christian-Albrechts-University Kiel, Germany DISCLOSURES Prof Röcken has reported no conflict of interest PATHOLOGICAL
More informationCREA PRINCIPLE SPECIMEN REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Creatinine REF 442760 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED
More informationIron Metabolism - Distribution. Anemias of Disordered Iron Metabolism and Heme Synthesis. Iron Metabolism Absorption. Iron Metabolism - Transport
Iron Metabolism - Distribution Anemias of Disordered Iron Metabolism and Heme Synthesis Iron-containing compounds Functional compounds metabolic (hemoglobin) or enzymatic functions Transport (transferrin)
More informationSupplementary Information
Electronic Supplementary Material (ESI) for Lab on a Chip. This journal is The Royal Society of Chemistry 2018 Supplementary Information Additional Methods The HYPER pad fabrication The HYPER pad has a
More informationLTBI Testing: Areas of Concern and Gray Zones
LTBI Testing: Areas of Concern and Gray Zones June 2, 2015 Masa Narita, MD Outline Positive Predictive Value LTBI testing in the general population Reproducibility Boosting Positive Predictive Value The
More informationSerum vs Plasma. Which specimen should you use? American Society for Clinical Laboratory Science Michigan Annual Meeting
Serum vs Plasma Which specimen should you use? American Society for Clinical Laboratory Science Michigan Annual Meeting Sol Green PhD FACB March 31 2016 Introduction This presentation is intended to provide
More informationSerum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins
Immunopathology / DETECTING SUBTLE FLC-PRODUCING M PROTEINS Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins Nasir A, Bakshi,
More informationFerrata Storti Foundation
Published Ahead of Print on December 8, 2009, as doi:10.3324/haematol.2009.018986. Copyright 2009 Ferrata Storti Foundation. Early Release Paper The -582A>G variant of the HAMP promoter is not associated
More informationORIGINAL ARTICLE. Latifah Anandari 1, Astuti Giantini 1
DOI: 10.22301/IJHMCR.2528-3189.05 Article can be accessed online on: http://www.ijhmcr.com International Journal of Health Medicine And Current Research Vol. 1, Issue 01, pp.05-11, September, 2016 ORIGINAL
More informationNON-INTERVENTIONAL STUDY ABSTRACT FOR EXTERNAL DISCLOSURE
NON-INTERVENTIONAL STUDY ABSTRACT FOR EXTERNAL DISCLOSURE Title: KIMS (Pfizer International Metabolic Database) Date of Abstract: 25 February 2015 Keywords: Growth hormone deficiency, Genotropin, hypopituitarism.
More information